Transient in vitro epigenetic reprogramming of skin fibroblasts into multipotent cells

Biomaterials

Volumn 31, Issue 10, 2010, Pages 2779-2787

  Zhu, Xiang Qing ^a   Pan, Xing Hua ^a   Wang, Weibo ^b   Chen, Qiang ^a   Pang, Rong Qing ^a   Cai, Xue Min ^a   Hoffman, Andrew R ^b   Hu, Ji Fan ^b  

^a Kunming Army General Hospital   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; Epigenetic reprogramming; Fish oocyte extracts; iMS cells; Induced multipotent stem cells; Multipotency

Indexed keywords

CLINICAL APPLICATION; CLINICAL RESEARCH; DEGENERATIVE DISEASE; DIFFERENTIATION; FISH OOCYTES; GENETIC DISORDERS; GENOMIC IMPRINTING; IN-VITRO; INSULIN-LIKE GROWTH FACTOR; MULTIPOTENT CELLS; PLURIPOTENT; POTENTIAL RISKS; REGENERATIVE MEDICINE; SHORT PERIODS; STEM CELL; TISSUE DAMAGE;

CELL CULTURE; FIBROBLASTS; GENE EXPRESSION; TISSUE;

STEM CELLS;

OCTAMER TRANSCRIPTION FACTOR 4; RNA H19; SOMATOMEDIN B; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CELL DIFFERENTIATION; CONTROLLED STUDY; EPIGENETICS; GENETIC ENGINEERING; GENOME IMPRINTING; IN VITRO STUDY; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; TERATOMA;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL EXTRACTS; CELL PROLIFERATION; EPIGENESIS, GENETIC; FIBROBLASTS; FISHES; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MICE; MULTIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; OOCYTES; RNA, UNTRANSLATED; SKIN; TERATOMA;

IPS;

EID: 75149129653     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.12.027     Document Type: Article

References (64)

1. Yang X., Smith S.L., Tian X.C., Lewin H.A., Renard J.P., and Wakayama T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet 39 (2007) 295-302
2. Tweedell K.S. New paths to pluripotent stem cells. Curr Stem Cell Res Ther 3 (2008) 151-162
3. Han Z., Vandevoort C.A., and Latham K.E. Therapeutic cloning: status and prospects. Curr Opin Mol Ther 9 (2007) 392-397
4. Hochedlinger K., and Jaenisch R. Nuclear reprogramming and pluripotency. Nature 441 (2006) 1061-1067
5. Tamada H., and Kikyo N. Nuclear reprogramming in mammalian somatic cell nuclear cloning. Cytogenet Genome Res 105 (2004) 285-291
6. Colman A. Somatic cell transfer in mammals: progress and applications. Cloning 1 (2000) 185-200
7. Shi W., Zakhartchenko V., and Wolf E. Epigenetic reprogramming in mammalian nuclear transfer. Differentiation 71 (2003) 91-113
8. Tada M., Tada T., Lefebvre L., Barton S.C., and Surani M.A. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. Embo J 16 (1997) 6510-6520
9. Tada M., Takahama Y., Abe K., Nakatsuji N., and Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11 (2001) 1553-1558
10. Do J.T., and Scholer H.R. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22 (2004) 941-949
11. Cowan C.A., Atienza J., Melton D.A., and Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309 (2005) 1369-1373
12. Taranger C.K., Noer A., Sorensen A.L., Hakelien A.M., Boquest A.C., and Collas P. Induction of dedifferentiation, genome wide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 16 (2005) 5719-5735
13. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
14. Meissner A., Wernig M., and Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25 (2007) 1177-1181
15. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
16. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146
17. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
18. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
19. Kim J.B., Zaehres H., Wu G., Gentile L., Ko K., Sebastiano V., et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 29 (2008) 29
20. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 14 (2008) 14
21. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
22. Mali P., Ye Z., Hommond H.H., Yu X., Lin J., Chen G., et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 29 (2008) 29
23. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4 (2009) 381-384
24. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., and Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458 (2009) 771-775
25. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136 (2009) 964-977
26. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin II, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324 (2009) 797-801
27. Hu J.F., Vu T.H., and Hoffman A.R. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. J Biol Chem 272 (1997) 20715-20720
28. Hu J.F., Oruganti H., Vu T.H., and Hoffman A.R. Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation. Mol Endocrinol 12 (1998) 220-232
29. Chen H.L., Li T., Qiu X.W., Wu J., Ling J.Q., Sun Z.H., et al. Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. Embo J 25 (2006) 5329-5338
30. Martys J.L., Shevell T., and McGraw T.E. Studies of transferrin recycling reconstituted in streptolysin O permeabilized Chinese hamster ovary cells. J Biol Chem 270 (1995) 25976-25984
31. Hansis C., Barreto G., Maltry N., and Niehrs C. Nuclear reprogramming of human somatic cells by Xenopus egg extract requires BRG1. Curr Biol 14 (2004) 1475-1480
32. Hu J.F., Vu T.H., and Hoffman A.R. Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. J Biol Chem 271 (1996) 18253-18262
33. Chen T.L., Shen W.J., Qiu X.W., Li T., Hoffman A.R., and Kraemer F.B. Generation of novel adipocyte monolayer cultures from embryonic stem cells. Stem Cells Dev 16 (2007) 371-380
34. Darabi R., Gehlbach K., Bachoo R.M., Kamath S., Osawa M., Kamm K.E., et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 14 (2008) 134-143
35. Shi Y., Hou L., Tang F., Jiang W., Wang P., Ding M., et al. Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells 23 (2005) 656-662
36. Zhang S.C., Wernig M., Duncan I.D., Brustle O., and Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19 (2001) 1129-1133
37. Hu J., Vu T., and Hoffman A. Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system. Mol Endocrinol 9 (1995) 628-636
38. Yang Y., Hu J.F., Ulner G., Li T., Yao X., Vu T.H., et al. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites. J Cell Biochem 90 (2003) 1038-1055
39. Humpherys D., Eggan K., Akutsu H., Hochedlinger K., Rideout III W.M., Biniszkiewicz D., et al. Epigenetic instability in ES cells and cloned mice. Science 293 (2001) 95-97
40. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (1998) 379-391
41. Cavaleri F., and Scholer H.R. Nanog: a new recruit to the embryonic stem cell orchestra. Cell 113 (2003) 551-552
42. Niwa H., Miyazaki J., and Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24 (2000) 372-376
43. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 (2003) 631-642
44. Chambers I., Silva J., Colby D., Nichols J., Nijmeijer B., Robertson M., et al. Nanog safeguards pluripotency and mediates germline development. Nature 450 (2007) 1230-1234
45. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122 (2005) 947-956
46. Kim J., Chu J., Shen X., Wang J., and Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132 (2008) 1049-1061
47. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38 (2006) 431-440
48. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
49. Woodbury D., Reynolds K., and Black I.B. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 69 (2002) 908-917
50. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 (2001) 211-228
51. Barry F.P., and Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36 (2004) 568-584
52. Boquest A.C., Shahdadfar A., Brinchmann J.E., and Collas P. Isolation of stromal stem cells from human adipose tissue. Methods Mol Biol 325 (2006) 35-46
53. Brennecke J., Stark A., Russell R.B., and Cohen S.M. Principles of microRNA-target recognition. PLoS Biol 3 (2005) e85
54. Mathieu O., and Bender J. RNA-directed DNA methylation. J Cell Sci 117 (2004) 4881-4888
55. Petersen C.P., Bordeleau M.E., Pelletier J., and Sharp P.A. Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21 (2006) 533-542
56. Valencia-Sanchez M.A., Liu J., Hannon G.J., and Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20 (2006) 515-524
57. Zamore P.D., and Haley B. Ribo-gnome: the big world of small RNAs. Science 309 (2005) 1519-1524
58. Cannell I.G., Kong Y.W., and Bushell M. How do microRNAs regulate gene expression?. Biochem Soc Trans 36 (2008) 1224-1231
59. Barroso-del Jesus A., Lucena-Aguilar G., and Menendez P. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 8 (2009) 394-398
60. Lin T.A., Tsay C., Chen C.H., Tang P.C., and Ju J.C. Nuclear and cytoskeletal dynamics during oocyte maturation and development of somatic cell cloned pig embryos injected with membrane disintegrated donor cells. Anim Reprod Sci 103 (2008) 107-119
61. Chang K.H., Lim J.M., Kang S.K., Lee B.C., Moon S.Y., and Hwang W.S. Blastocyst formation, karyotype, and mitochondrial DNA of interspecies embryos derived from nuclear transfer of human cord fibroblasts into enucleated bovine oocytes. Fertil Steril 80 (2003) 1380-1387
62. Zhang S., Wang J., Bilen M.A., Lin S.H., Stupp S.I., and Satcher R.L. Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts. Clin Exp Metastasis 29 (2009) 29
63. Bouziges F., Simo P., Simon-Assmann P., Haffen K., and Kedinger M. Altered deposition of basement-membrane molecules in co-cultures of colonic cancer cells and fibroblasts. Int J Cancer 48 (1991) 101-108
64. Grinnell K.L., and Bickenbach J.R. Skin keratinocytes pre-treated with embryonic stem cell-conditioned medium or BMP4 can be directed to an alternative cell lineage. Cell Prolif 40 (2007) 685-705